Catalent | CTLT - Selling And Administration Expenses


Catalent reported $252M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.



Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Centene USD 3.37B 236M Dec/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cigna USD 3.19B 242M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Glaxosmithkline GBP 2.91B 817.89M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 283M 27M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.75B 831M Dec/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
McKesson USD 2.03B 44M Dec/2025
Merck EUR 1.46B 16M Sep/2025
Merck USD 2.85B 215M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Quest Diagnostics USD 504M 3M Dec/2025
Repligen USD 73.66M 2.43M Sep/2025
Revvity USD 251.73M 9.82M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Waters USD 240.01M 25.78M Dec/2025
West Pharmaceutical Services USD 106.5M 3.8M Dec/2025